can semaglutide cause kidney issues semaglutide's protection against chronic kidney disease - Semaglutide kidneypain reddit renal damage Can Semaglutide Cause Kidney Issues? Examining the Evidence

CanOzempic damage kidneys The emergence of semaglutide, a GLP-1 receptor agonist known by brand names such as Ozempic and Wegovy, has brought significant advancements in managing type 2 diabetes and promoting weight loss. However, as with any medication, questions arise regarding potential side effects, particularly concerning kidney health. While recent research suggests semaglutide may actually offer kidney protective effects, it's crucial to address the existing discourse and scientific understanding of whether semaglutide can cause kidney issues.

It is important to acknowledge that there have been a number of postmarketing reports of acute kidney injury (AKI) and worsening chronic kidney disease (CKD) in patients taking the GLP-1 receptor agonist semaglutide. These reports are a critical component of understanding a drug's safety profile. However, scientific literature also emphasizes that it is not always possible to definitively determine whether an event is truly caused by the drug as opposed to the underlying medical conditions of the patient or concomitant medications. For instance, severe gastrointestinal symptoms, which can include nausea, vomiting, and diarrhea, are known side effects of semaglutide. These symptoms, if severe, can lead to dehydration, and dehydration can in turn lead to serious kidney problems, including acute kidney injuryOn the FDA label for Ozempic, “acute kidney injury and worsening of chronicrenal failure” is listed as a potential adverse reaction. This may be .... Therefore, in some instances, semaglutide may be indirectly linked to kidney issues through these adverse reactions.

Further complicating the narrative, recent clinical trials have presented promising findings regarding semaglutide's impact on kidney health. Studies suggest that semaglutide not only mitigates kidney-related outcomes but can also enhance cardiovascular health and reduce mortality.The FLOW study: Effects of Semaglutide on chronic kidney ... Evidence indicates that semaglutide could potentially prevent kidney failure and reduce deaths for individuals living with type 2 diabetes. In the SELECT trial, for example, semaglutide safeguarded against cardiovascular complications and demonstrated slower progression in kidney disease in patients with type 2 diabetes. In one study involving 3533 patients with type 2 diabetes and chronic kidney disease, treatment with semaglutide significantly reduced the risk of adverse kidney outcomes. Specifically, a median follow-up of 3.4 years showed that semaglutide (1 mg subcutaneously once weekly) decreased the primary kidney outcome by 24% compared to placebo. Another analysis indicated that semaglutide lowered the risk of kidney failure or serious kidney problems by 24% and slowed the progression of kidney disease.

The mechanism behind these protective effects is multifaceted. Beyond its primary role in glycemic control, semaglutide's mechanisms of action appear to influence metabolic and hemodynamic pathways that can contribute to renal damage. For individuals with normal kidney function, studies have not shown semaglutide to have a significant effect on the decline of estimated glomerular filtration rate (eGFR). Furthermore, semaglutide and similar GLP-1 receptor agonists like liraglutide are not primarily cleared by the kidneys and do not directly damage renal tissue.

While the focus has often been on semaglutide and its potential for adverse events, it's also important to consider the broader context of GLP-1 medicines and kidney disease.These may be symptoms of dehydration whichcan lead toseriouskidney problem. This medicine maycausesevere stomach or bowel problems. Check with your ... The FDA label for Ozempic (a brand name for semaglutide) does list "acute kidney injury and worsening of chronic renal failure" as a potential adverse reaction. However, current evidence suggests that GLP-1 receptor agonists do not increase the overall risk of AKI at a population level.

It is essential for patients to have open and honest conversations with their healthcare providers about any concerns regarding semaglutide and its potential impact on their kidney health.... The AKI is usually driven by dehydration from the GI symptoms initiallycausedby GLP-1RAs. AKI has also been reported with liraglutide andsemaglutide[152 ... Healthcare professionals can assess individual risk factors, monitor kidney function, and provide guidance on managing potential side effects. While rare cases of semaglutide-induced acute kidney injury have been reported, often occurring in individuals with pre-existing conditions, the emerging body of research highlights the potential of semaglutide as a therapeutic agent that may actually improve kidney outcomes for many patients. The ongoing research into semaglutide's long-term kidney outcomes in obesity and cardiovascular disease continues to shed light on its complex relationship with renal health2024年3月22日—Results from a recent clinical trial show promise forsemaglutide as a treatment to help slow progression of kidney diseaseand reduce the risk of death from ....